This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dirnagl, U. Articles by Meisel, A. Search for Related Content PubMed PubMed Citation Articles by Dirnagl, U. Articles by Meisel, A. Related Collections Animal models of human disease Acute Cerebral Infarction Other Stroke Treatment - Medical

(Stroke. 2007;38:770.)
© 2007 American Heart Association, Inc.

Adaptive Immunity: Introduction

Stroke-Induced Immunodepression

Experimental Evidence and Clinical Relevance

Ulrich Dirnagl, MD; Juliane Klehmet, MD; Johann S. Braun, MD; Hendrik Harms, MD; Christian Meisel, MD; Tjalf Ziemssen, MD; Konstantin Prass, MD Andreas Meisel, MD

From Department of Neurology (U.D., J.K., J.S.B., H.H., K.P., A.M.), Department of Experimental Neurology, Center for Stroke Research and Department of Medical Immunology (C.M.), Charité Universitätsmedizin, Berlin, Germany; Department of Neurology (T.Z.), University of Dresden, Germany.

Correspondence to Prof Dr Ulrich Dirnagl, Department of Experimental Neurology, Charite Universitätsmedizin Berlin, Charitéplatz 1, 10098 Berlin, Germany. E-mail ulrich.dirnagl{at}charite.de

Abstract

Stroke affects the normally well-balanced interplay of the 2 supersystems: the nervous and the immune system. Recent research elucidated some of the involved signals and mechanisms and, importantly, was able to demonstrate that brain-immune interactions are highly relevant for functional outcome after stroke. Immunodepression after stroke increases the susceptibility to infection, the most relevant complication in stroke patients. However, immunodepression after stroke may also have beneficial effects, for example, by suppressing autoaggressive responses during lesion-induced exposure of central nervous system-specific antigens to the immune system. Thus, before immunomodulatory therapy can be applied to stroke patients, we need to understand better the interaction of brain and immune system after focal cerebral ischemia. Until then, anticipating an important consequence of stroke-induced immunodepression, bacterial infection, preventive antibiotic strategies have been proposed. In mouse experiments, preventive antibiotic treatment dramatically improves mortality and outcome. Results of clinical studies on this issue are contradictory at present, and larger trials are needed to settle the question whether (and which) stroke patients should be preventively treated. Nevertheless, clinical evidence is emerging demonstrating that stroke-induced immunodepression in humans not only exists, but has very similar features to those characterized in rodent experiments.

Key Words: brain infarction • brain ischemia • experimental • focal ischemia • immunology • infectious disease • inflammation • treatment

This article has been cited by other articles:

				A. Hug, A. Dalpke, N. Wieczorek, T. Giese, A. Lorenz, G. Auffarth, A. Liesz, and R. Veltkamp Infarct Volume is a Major Determiner of Post-Stroke Immune Cell Function and Susceptibility to Infection Stroke, October 1, 2009; 40(10): 3226 - 3232. [Abstract] [Full Text] [PDF]

				A. Liesz, S. Hagmann, C. Zschoche, J. Adamek, W. Zhou, L. Sun, A. Hug, M. Zorn, A. Dalpke, P. Nawroth, et al. The Spectrum of Systemic Immune Alterations After Murine Focal Ischemia: Immunodepression Versus Immunomodulation Stroke, August 1, 2009; 40(8): 2849 - 2858. [Abstract] [Full Text] [PDF]

				S. Subramanian, B. Zhang, Y. Kosaka, G. G. Burrows, M. R. Grafe, A. A. Vandenbark, P. D. Hurn, and H. Offner Recombinant T Cell Receptor Ligand Treats Experimental Stroke Stroke, July 1, 2009; 40(7): 2539 - 2545. [Abstract] [Full Text] [PDF]

				M. Gelderblom, F. Leypoldt, K. Steinbach, D. Behrens, C.-U. Choe, D. A. Siler, T. V. Arumugam, E. Orthey, C. Gerloff, E. Tolosa, et al. Temporal and Spatial Dynamics of Cerebral Immune Cell Accumulation in Stroke Stroke, May 1, 2009; 40(5): 1849 - 1857. [Abstract] [Full Text] [PDF]

				X. Urra, A. Cervera, V. Obach, N. Climent, A. M. Planas, and A. Chamorro Monocytes Are Major Players in the Prognosis and Risk of Infection After Acute Stroke Stroke, April 1, 2009; 40(4): 1262 - 1268. [Abstract] [Full Text] [PDF]

				S. Schwarz, F. Al-Shajlawi, C. Sick, S. Meairs, and M. G. Hennerici Effects of Prophylactic Antibiotic Therapy With Mezlocillin Plus Sulbactam on the Incidence and Height of Fever After Severe Acute Ischemic Stroke: The Mannheim Infection in Stroke Study (MISS) Stroke, April 1, 2008; 39(4): 1220 - 1227. [Abstract] [Full Text] [PDF]

				S.-T. Lee, K. Chu, K.-H. Jung, S.-J. Kim, D.-H. Kim, K.-M. Kang, N. H. Hong, J.-H. Kim, J.-J. Ban, H.-K. Park, et al. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke Brain, March 1, 2008; 131(3): 616 - 629. [Abstract] [Full Text] [PDF]

				A. Vogelgesang, U. Grunwald, S. Langner, R. Jack, B. M. Broker, C. Kessler, and A. Dressel Analysis of Lymphocyte Subsets in Patients With Stroke and Their Influence on Infection After Stroke Stroke, January 1, 2008; 39(1): 237 - 241. [Abstract] [Full Text] [PDF]